+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "CRISPR"

From
From
From
From
From
From
From
AI in Genomics Market Report and Forecast 2025-2034 - Product Thumbnail Image

AI in Genomics Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Genomics Market Report and Forecast 2025-2034 - Product Thumbnail Image

Genomics Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Cell Therapy Market Report and Forecast 2025-2034 - Product Thumbnail Image

Cell Therapy Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Transformational Power of Genomics in Pharma - Product Thumbnail Image

Transformational Power of Genomics in Pharma

  • Report
  • April 2025
  • 59 Pages
  • Global
From
Cell and Gene Therapies - Current and Future Landscape - Product Thumbnail Image

Cell and Gene Therapies - Current and Future Landscape

  • Report
  • November 2024
  • 82 Pages
  • Global
From
From
Genomics Market Overview, 2025-30 - Product Thumbnail Image

Genomics Market Overview, 2025-30

  • Report
  • June 2025
  • 106 Pages
  • Global
From
Genomics Market Outlook, 2030 - Product Thumbnail Image

Genomics Market Outlook, 2030

  • Report
  • June 2025
  • 194 Pages
  • Global
From
Loading Indicator

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population. The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more